Patented Medicine Prices Review Board - Economic Action Plan 2012
||Planned Savings (In 000s)
|Administrative Efficiencies and Rationalization of Structures and Functions (1)
|Reduction of funding for the Non-patented
Prescription Drug Prices Program
|Streamlining Regulatory Operations and Administration (2)
|Reduction of the Special Purpose Allotment for
|TOTAL - Patented Medicine Prices Review Board:
(1) This measure applies to the Pharmaceutical Trends Program program activity.
(2) This measure applies to the Patented Medicine Prices Regulation Program program activity.